Karen L. Smith - Nov 21, 2024 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Karen L. Smith
Stock symbol
AUPH
Transactions as of
Nov 21, 2024
Transactions value $
$0
Form type
4
Date filed
11/25/2024, 04:38 PM
Previous filing
Nov 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Shares Award $0 +12.1K +95.76% $0.00 24.8K Nov 21, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Director Stock Option (right to buy) Award $0 +18.6K $0.00 18.6K Nov 21, 2024 Common Shares 18.6K $8.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
F2 The options shall vest one year from date of grant.